Sherwin-Williams
SHW
$345.63
+2.48%
The Sherwin-Williams Company is the largest global manufacturer of paints and coatings, developing, producing, and distributing architectural paint, industrial coatings, and related products through three segments: the company-owned Paint Stores Group (over 4,800 stores serving professional contractors and DIY consumers), the Consumer Brands Group (branded paint sold through big-box retailers such as Lowe's), and the Performance Coatings Group (automotive refinishing, packaging, and industrial wood coatings). Its competitive identity rests on a vertically integrated, company-controlled distribution model that gives it unmatched specification control with professional painters, a moat that has supported 47 consecutive years of dividend increases and premium returns on equity above 55%. The current investor narrative centers on a cyclical recovery in architectural coatings demand after a prolonged housing and remodeling slump, with Q2 2026 revenue up 7.5% year over year to $6.79 billion and gross margin holding near 49.2% despite soft new-home construction. Debate now hinges on whether volume recovery can persist into 2027 against a still-weak housing backdrop, how management deploys roughly $3.2 billion of trailing free cash flow between buybacks and debt reduction after the recent acquisition activity, and whether the stock's rich multiple can be defended if the demand rebound proves shallow.…
SHW
Sherwin-Williams
$345.63
Related headlines
Investment Opinion: Should I buy SHW Today?
Rating: Hold with a bullish bias. The core thesis is that Sherwin-Williams is a high-quality franchise with an elite distribution moat and improving fundamentals, but the current valuation of 31.2x trailing PE and 24.8x forward PE already reflects much of the recovery, limiting near-term upside to the analyst average target of $383.13 (+14.3%). The consensus recommendation is buy (mean 2.07), and the lowest target of $340 is above the current price, providing a valuation cushion.
Supporting evidence: revenue grew 7.52% year over year in Q2 2026 to $6.789 billion, gross margin expanded to 49.17% from 46.03% in Q2 2023, operating margin reached 18.13%, and trailing free cash flow of $3.213 billion comfortably covers the dividend and buybacks. ROE of 55.86% is elite, and the 30.7% payout ratio leaves room for continued capital returns. The forward PE of 24.8x implies roughly 26% EPS growth to consensus $16.55, which is achievable if the recovery persists.
Risks and conditions: the biggest risks are a stall in the housing recovery, margin pressure from raw materials or competition, and valuation compression given the premium multiple. This Hold would upgrade to Buy if the stock pulls back toward $300 (roughly 20x forward EPS) or if revenue growth accelerates above 10% with margin expansion. It would downgrade to Sell if revenue growth decelerates below 5% or if gross margin falls below 47%. Valuation verdict: fairly valued relative to its own history (trailing PE below the 41.8x at Q4 2025) but at a premium to peers, suggesting the stock is priced for a moderate recovery rather than a bargain.
Sign up to view all
SHW 12-Month Price Forecast
Sherwin-Williams is a high-quality franchise with an elite distribution moat, improving margins, and strong cash generation, but the stock's premium valuation and negative relative strength suggest the easy money has been made. The base case (50% probability) targets $370-$390, in line with the analyst average of $383.13, assuming mid-single-digit revenue growth and stable margins. The bull case (30%) requires an acceleration in housing recovery and multiple expansion to $400-$420, while the bear case (20%) sees a stall driving the stock to $290-$340. I would upgrade to bullish if revenue growth accelerates above 10% with gross margin above 49%, or if the stock pulls back to $300 (20x forward EPS). I would downgrade to bearish if gross margin falls below 47% or if housing data deteriorates further.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Sherwin-Williams's 12-month outlook, with a consensus price target around $383.13 and implied upside of +10.8% versus the current price.
Average Target
$383.13
0 analysts
Implied Upside
+10.8%
vs. current price
Analyst Count
—
covering this stock
Price Range
$340 - $420
Analyst target range
Coverage is broad and constructive: 24 analysts cover SHW with a consensus recommendation of "buy" (mean rating 2.07 on a scale where lower is more bullish), and the average target price of $383.13 implies +14.3% upside from the current $335.20. The consensus leans bullish but not aggressively so — the average target sits just 1.4% above the 52-week high of $377.77, meaning analysts collectively expect the stock to reclaim and slightly exceed its prior peak, which is a meaningful vote of confidence in the cyclical recovery. Notably, the lowest target of $340.00 is still above the current price, implying that even the most cautious analyst sees no downside from here, a rare configuration that suggests the recent pullback has created a valuation cushion relative to published estimates. The target range of $340 to $420 is moderately wide (23.5% spread from low to high), signaling differentiated views on the pace of the housing recovery and margin durability. The high target of $420 assumes multiple expansion back toward the mid-30s PE alongside the $16.55 consensus EPS, effectively pricing in both earnings delivery and a re-rating as housing turnover improves; the low target of $340 essentially assumes the stock merely holds its current multiple on consensus earnings, implying flat-to-modest growth with no re-rating. Institutional ratings show a stable-to-positive pattern — RBC Capital reiterated Outperform on September 22 and 25, JP Morgan, Morgan Stanley, and BMO all reiterated Overweight/Outperform after Q2 earnings on July 29, and Citigroup maintained Buy in June — with Wells Fargo the lone Equal Weight hold, indicating no recent downgrades and a consensus that is holding firm through the recent volatility.
Bulls vs Bears: SHW Investment Factors
The bull case rests on tangible fundamental improvement: 7.5% revenue growth, 310 bps of gross margin expansion over three years, elite 55.9% ROE, and $3.2 billion of trailing free cash flow, all supported by a consensus buy rating with 14.3% upside to the average target. The bear case centers on relative underperformance (-14.4 points versus the S&P 500 over one year), a premium valuation of 31.2x trailing PE versus a sector typically in the high-teens to low-20s, and a leveraged balance sheet with a current ratio of 0.868. On balance, the bull evidence is currently stronger because the fundamental momentum is measurable and improving, while the bear points are largely about valuation and relative performance that could reverse if the recovery persists. The single most important tension is whether the architectural coatings volume recovery can sustain into 2027 against a still-weak housing backdrop; if it does, the forward PE of 24.8x will look reasonable and the stock can re-rate toward the $420 high target, but if it stalls, the premium multiple is vulnerable to compression toward the $340 low target.
Bullish
- Revenue reaccelerating at 7.5% YoY: Q2 2026 revenue of $6.789 billion grew 7.52% year over year versus $6.315 billion in Q2 2025, and the sequential cadence shows the seasonal peak strengthening. Consensus revenue of $28.89 billion for the year implies continued mid-single-digit growth, supporting the cyclical recovery thesis.
- Gross margin expansion of 310 bps: Gross margin reached 49.17% in Q2 2026, up from 48.23% in Q1 2025 and 46.03% in Q2 2023, reflecting pricing power and raw-material normalization. Operating margin of 18.13% also improved versus 14.31% in Q1 2026 and 13.92% in Q4 2025.
- Elite ROE and strong free cash flow: ROE of 55.86% and ROA of 9.52% are exceptional, while trailing free cash flow of $3.213 billion comfortably funds the $197.5 million quarterly dividend and $1.261 billion of Q2 buybacks. The 30.7% payout ratio leaves ample room for continued capital returns.
- Analyst consensus buy with 14.3% upside: 24 analysts rate SHW a buy (mean 2.07) with an average target of $383.13, implying 14.3% upside from $335.20. Notably, the lowest target of $340 is above the current price, suggesting even cautious analysts see no downside.
Bearish
- Relative strength deeply negative: SHW is up just 1.13% over the past year versus a 15.53% gain for the S&P 500, a relative strength gap of -14.40 percentage points. The stock sits at roughly 51.6% of its 52-week range, reflecting a market that has neither capitulated nor embraced the name.
- Rich valuation versus sector: The trailing PE of 31.2x and forward PE of 24.8x represent a meaningful premium of roughly 30-50% above the typical specialty chemicals sector mid-point. The 3.39x PS and 20.65x EV/EBITDA are also rich for a coatings manufacturer, leaving little room for execution error.
- Leveraged balance sheet and weak liquidity: Debt-to-equity of 2.81x and a current ratio of 0.868 reflect the leveraged, asset-light store model. Interest expense rose to $135.9 million in Q2 2026 from $112.4 million a year earlier, a modest but growing drag.
- Housing market remains a headwind: The architectural coatings recovery is early and dependent on a still-weak housing backdrop. Q1 2026 free cash flow was only $0.8 million due to working-capital seasonality, so liquidity depends on the seasonal cash harvest in Q2-Q3.
SHW Technical Analysis
SHW is in a range-bound consolidation rather than a clean trend: the stock is up just 1.13% over the past year versus a 15.53% gain for the S&P 500, a relative strength gap of -14.40 percentage points, and it sits at roughly 51.6% of its 52-week range ($289.86 low to $377.77 high) with a current price of $335.20. That mid-range positioning reflects a market that has neither capitulated nor embraced the name — the -21.36% max drawdown over the period shows how sharply the stock sold off from its highs, while the recovery back above $330 signals buyers defending the low-$300s. With a beta of 1.083, SHW carries modestly more volatility than the market, so the mid-range stall is less about risk appetite and more about a lack of fundamental catalysts. Recent momentum is improving but uneven: the stock is up 4.27% over the past month (beating SPY by 3.05 points) and 1.17% over three months, yet down 3.00% over six months and only up 2.25% year-to-date versus SPY's 11.93%. The one-month outperformance against a negative six-month trend is a classic mean-reversion signature — the October rally from $315 on October 7 to $336.92 on October 15 (+7.0% in six sessions) looks like short covering and dip-buying rather than a confirmed trend reversal, especially with the 1-year relative strength still deeply negative at -14.40. Key levels are well defined: support sits at the $289.86 52-week low, with secondary support around the $300-$310 zone that held repeatedly in May and June; resistance is the $377.77 52-week high, with the $350-$370 band (touched in August) acting as the immediate ceiling. A breakout above $370 on volume would confirm a new uptrend and likely force underweight managers to chase, while a breakdown below $300 would signal the cyclical recovery thesis is failing and open the door to retesting the 52-week low; given the 1.083 beta and 4.02 short ratio, position sizing should assume roughly market-level volatility with elevated event risk around earnings.
Beta
1.08
1.08x market volatility
Max Drawdown
-21.4%
Largest decline past year
52-Week Range
$290-$378
Price range past year
Annual Return
+3.5%
Cumulative gain past year
| Period | SHW Return | S&P 500 |
|---|---|---|
| 1m | +5.3% | -1.2% |
| 3m | +8.9% | +3.4% |
| 6m | +2.3% | +7.0% |
| 1y | +3.5% | +14.4% |
| ytd | +5.4% | +12.0% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
SHW Fundamental Analysis
Revenue is reaccelerating from a low base: Q2 2026 revenue of $6.789 billion grew 7.52% year over year versus $6.315 billion in Q2 2025, and the sequential cadence ($5.667 billion in Q1 2026, $5.596 billion in Q4 2025, $6.358 billion in Q3 2025) shows the seasonal peak strengthening year over year. Segment data reveals the mix: Paint Stores Group at $3.890 billion is the growth engine and margin anchor, Consumer Group at $2.539 billion and Global Finishes at $1.930 billion provide diversification, while corporate eliminations of -$1.570 billion reflect inter-segment sales. The trajectory implies the architectural recovery is real but early — consensus revenue of $28.89 billion for the year implies continued mid-single-digit growth, which is the key swing factor for the investment case. Profitability is solid and improving: Q2 2026 net income of $843.6 million on a 12.43% net margin, gross margin of 49.17% (up from 48.23% in Q1 2025 and 46.03% in Q2 2023), and operating margin of 18.13% versus 14.31% in Q1 2026 and 13.92% in Q4 2025. The gross margin expansion of roughly 310 basis points over three years reflects pricing power and raw-material normalization, while the 16.14% operating margin (TTM) and 10.90% net margin are strong for specialty chemicals. Interest expense of $135.9 million in Q2 2026 versus $112.4 million a year earlier is a modest drag, but EBITDA of $1.248 billion (18.39% margin) confirms the earnings quality is intact. The balance sheet is the main watch item: debt-to-equity of 2.81x and a current ratio of 0.868 reflect the leveraged, asset-light store model, but free cash flow of $3.213 billion TTM and $1.239 billion in Q2 2026 alone comfortably fund the $197.5 million quarterly dividend and $1.261 billion of Q2 buybacks. ROE of 55.86% and ROA of 9.52% are elite, and the 30.7% payout ratio leaves ample room for continued capital returns; the risk is that Q1 2026 free cash flow was only $0.8 million due to working-capital seasonality, so liquidity depends on the seasonal cash harvest in Q2-Q3.
Quarterly Revenue
$6.8B
2026-06
Revenue YoY Growth
+7.5%
YoY Comparison
Gross Margin
49.2%
Latest Quarter
Free Cash Flow
$3.2B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is SHW Overvalued?
Because Sherwin-Williams is solidly profitable (Q2 2026 net income of $843.6 million), the PE ratio is the primary metric: the trailing PE of 31.2x versus a forward PE of 24.8x implies the market expects roughly 26% EPS growth over the next twelve months, consistent with consensus EPS of $16.55 versus the current run-rate. The 6.5-turn gap between trailing and forward multiples is wide and signals that analysts are underwriting a cyclical earnings recovery — if that recovery slips, the forward multiple is vulnerable. On the secondary metrics, the 3.39x PS ratio and 20.65x EV/EBITDA are rich for a coatings manufacturer, while the 17.36x price-to-book reflects the negative-equity-like leverage of the store network rather than a premium on assets. Peer comparison is constrained by the absence of an explicit industry-average multiple in the provided data, but the specialty chemicals sector typically trades in the high-teens to low-20s PE range; SHW's 31.2x trailing and 24.8x forward PE represent a meaningful premium (roughly 30-50% above a typical sector mid-point), which is defensible given its 55.9% ROE, 49.2% gross margin, and dominant distribution moat but leaves little room for execution error. Against its own history, the picture is more balanced: the trailing PE of 31.2x sits below the 41.8x recorded at Q4 2025 and the 36.8x at Q1 2026, and well below the 55.7x at Q4 2023, but above the 24.95x at Q2 2026 and the 20.8x at Q2 2024. In other words, the stock is in the middle-to-lower portion of its multi-year valuation band — not a bargain, but no longer at the euphoric multiples of 2023-2025, suggesting the market has already de-rated the name for slower growth and the current price embeds a moderately optimistic but not extreme recovery scenario.
PE
31.2x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 19x~56x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
20.6x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks are moderate but real. Debt-to-equity of 2.81x and a current ratio of 0.868 reflect the leveraged, asset-light store model, and interest expense rose to $135.9 million in Q2 2026 from $112.4 million a year earlier. Free cash flow is highly seasonal, with Q1 2026 at only $0.8 million versus $1.239 billion in Q2 2026, so liquidity depends on the Q2-Q3 cash harvest. Revenue concentration in the Paint Stores Group ($3.890 billion of Q2 2026 revenue) ties the company closely to professional contractor demand, which is sensitive to housing turnover and remodeling activity.
Market and competitive risks center on valuation compression. The trailing PE of 31.2x and forward PE of 24.8x represent a 30-50% premium to the typical specialty chemicals sector mid-point, leaving little room for execution error. With a beta of 1.083, SHW carries modestly more volatility than the market, and the -14.40 percentage point relative strength gap over one year shows the stock has lagged significantly. Recent news highlights geopolitical tensions and Fed uncertainty driving broad market sell-offs, which could disproportionately pressure premium-multiple names like SHW.
Worst-case scenario: a stall in the housing recovery combined with margin pressure from raw-material inflation or competitive pricing would compress the forward PE toward the low target of $340, and a deeper downturn could retest the 52-week low of $289.86. From the current price of $335.20, that represents a decline of approximately -13.5% to the $289.86 low, or roughly -21.4% based on the stock's max drawdown over the past year. A more severe scenario involving a recession and multiple compression to 20x forward EPS of $16.55 would imply a price near $331, roughly flat, but if EPS estimates are cut to $15 and the multiple compresses to 20x, the stock could fall to $300, a -10.5% decline.
FAQ
The most severe risk is a stall in the housing recovery, which would pressure revenue growth and the premium multiple, potentially driving the stock toward the 52-week low of $289.86 (-13.5%). Financial risk is moderate, with debt-to-equity of 2.81x and a current ratio of 0.868, though $3.2 billion in free cash flow provides flexibility. Competitive risk includes price pressure in the Consumer Brands segment and raw-material inflation that could erode the 49.17% gross margin. Macro risk is elevated with a beta of 1.083, meaning SHW is slightly more volatile than the market, and geopolitical tensions or Fed uncertainty could disproportionately impact premium-multiple stocks.
The 12-month forecast has three scenarios: a base case (50% probability) targeting $370-$390, in line with the analyst average of $383.13, assuming mid-single-digit revenue growth and stable margins; a bull case (30%) targeting $400-$420 if housing recovery accelerates and the multiple expands; and a bear case (20%) targeting $290-$340 if growth stalls or margins compress. The most likely scenario is the base case, which assumes revenue grows in line with consensus of $28.89 billion and EPS meets the $16.55 estimate. The key assumption is that the housing market remains soft but stable, with no further deterioration.
SHW trades at a trailing PE of 31.2x and a forward PE of 24.8x, which is a 30-50% premium to the typical specialty chemicals sector mid-point in the high-teens to low-20s. However, relative to its own history, the trailing PE is below the 41.8x at Q4 2025 and well below the 55.7x at Q4 2023, suggesting the stock has de-rated. The 3.39x PS and 20.65x EV/EBITDA are also rich. The market is paying a premium for SHW's 55.9% ROE and distribution moat, but the valuation implies the market expects the cyclical recovery to continue. If growth stalls, the multiple could compress toward 20x forward EPS, implying a price near $331, roughly flat from current levels.
SHW is a high-quality franchise with a 47-year dividend increase streak, 55.86% ROE, and $3.2 billion in trailing free cash flow, but the current valuation of 31.2x trailing PE and 24.8x forward PE limits the margin of safety. The analyst average target of $383.13 implies 14.3% upside, and the lowest target of $340 is above the current price, suggesting limited downside according to analysts. However, the stock has lagged the S&P 500 by 14.40 percentage points over the past year, and a stall in the housing recovery could compress the multiple. For long-term investors with a 2-3 year horizon, SHW is a reasonable buy on pullbacks toward $300, but at $335 it is fairly valued with moderate upside.
SHW is best suited for long-term investment given its 47-year dividend increase streak, 55.86% ROE, and dominant distribution moat, which compound value over time. The stock's beta of 1.083 and 4.02 short ratio suggest moderate volatility, making it less ideal for short-term trading. The dividend yield of 0.99% is modest, so total return depends on capital appreciation. Earnings visibility is moderate, with consensus EPS of $16.55 for the year, but the cyclical nature of housing means quarterly results can be volatile. A minimum holding period of 2-3 years is recommended to ride out the housing cycle and benefit from the recovery.